Literature DB >> 29956024

Extremely and pandrug-resistant bacteria extra-deaths: myth or reality?

Cédric Abat1, Pierre-Edouard Fournier2, Marie-Thérèse Jimeno2, Jean-Marc Rolain3,4, Didier Raoult5,6.   

Abstract

In 2009, the European Centre for Disease Prevention and Control (ECDC) estimated that multidrug-resistant (MDR) bacterial infections were responsible for 25,000 extra-deaths per year. In 2015, another report estimated that 12,500 extra-deaths were attributable to MDR bacteria every year in France. Recently, the United Nations claimed that resistance to antimicrobials was a global scourge, forecasting 10 million deaths in 2050. Surprisingly, our antibiotic resistance surveillance system in Marseille, France, did not allowed us to observe similar trends. We herein compared our data on extremely drug-resistant (XDR)/pandrug-resistant (PDR) patient extra-deaths to evaluations and predictions from these reports. First, we retrospectively collect and analyze antibiotic resistance data produced by our settings between November 2009 and March 2015 to look for 30-day deaths attributable to XDR/PDR strains belonging to 11 bacterial species/genus. In parallel, we performed a PubMed literature search to look for articles published prior to July 2016 and describing human deaths due to PDR strains. Overall, 35,723 patients were infected by at least one bacterial species/genus of interest and 85 by XDR/PDR strains. Of these patients, only one death was attributable to a XDR bacterial infection in a patient with strong comorbidities and two consecutive septic shocks. Our literature review shows that only four articles described human deaths due to PDR bacteria. All together, these data allowed us to conclude that there is a large discrepancy between the real count of deaths attributable to XDR/PDR bacteria and alarmist predictions.

Entities:  

Keywords:  Antibiotic resistance; Empirical data; Extra-deaths; Multidrug-resistant bacteria; Old antimicrobial drugs

Mesh:

Substances:

Year:  2018        PMID: 29956024     DOI: 10.1007/s10096-018-3300-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.

Authors:  Grégory Dubourg; Liliane Okdah; Stéphanie Le Page; Jean-Marc Rolain; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2015-10-20       Impact factor: 5.283

2.  Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.

Authors:  Raúl Recio; Jennifer Villa; Esther Viedma; María Ángeles Orellana; Jaime Lora-Tamayo; Fernando Chaves
Journal:  Int J Antimicrob Agents       Date:  2018-04-03       Impact factor: 5.283

Review 3.  Do we need new antibiotics?

Authors:  J-M Rolain; C Abat; M-T Jimeno; P-E Fournier; D Raoult
Journal:  Clin Microbiol Infect       Date:  2016-03-26       Impact factor: 8.067

4.  Ten key points for the appropriate use of antibiotics in hospitalised patients: a consensus from the Antimicrobial Stewardship and Resistance Working Groups of the International Society of Chemotherapy.

Authors:  Gabriel Levy Hara; Souha S Kanj; Leonardo Pagani; Lilian Abbo; Andrea Endimiani; Heiman F L Wertheim; Carlos Amábile-Cuevas; Pierre Tattevin; Shaheen Mehtar; Fernando Lopes Cardoso; Serhat Unal; Ian Gould
Journal:  Int J Antimicrob Agents       Date:  2016-07-25       Impact factor: 5.283

5.  The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.

Authors:  C Dobbin; M Maley; J Harkness; R Benn; M Malouf; A Glanville; P Bye
Journal:  J Hosp Infect       Date:  2004-04       Impact factor: 3.926

6.  Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.

Authors:  Denis Hadjiliadis; Mark P Steele; Cecilia Chaparro; Lianne G Singer; Thomas K Waddell; Michael A Hutcheon; Robert D Davis; Diana E Tullis; Scott M Palmer; Shaf Keshavjee
Journal:  J Heart Lung Transplant       Date:  2007-07-12       Impact factor: 10.247

Review 7.  Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.

Authors:  Azza Elemam; Joseph Rahimian; William Mandell
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

8.  Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.

Authors:  Matthew E Falagas; Giannoula S Tansarli; Drosos E Karageorgopoulos; Konstantinos Z Vardakas
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

Review 9.  Pseudomonas aeruginosa ventilator-associated pneumonia management.

Authors:  Sergio Ramírez-Estrada; Bárbara Borgatta; Jordi Rello
Journal:  Infect Drug Resist       Date:  2016-01-20       Impact factor: 4.003

10.  Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

Authors:  Marlieke E A de Kraker; Andrew J Stewardson; Stephan Harbarth
Journal:  PLoS Med       Date:  2016-11-29       Impact factor: 11.069

View more
  7 in total

1.  No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France.

Authors:  Stéphanie Le Page; Gregory Dubourg; Sophie Alexandra Baron; Jean-Marc Rolain; Didier Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-12-04       Impact factor: 3.267

2.  Treatment pattern, prognostic factors, and outcome in patients with infection due to pan-drug-resistant gram-negative bacteria.

Authors:  Diamantis P Kofteridis; Angeliki M Andrianaki; Sofia Maraki; Anna Mathioudaki; Marina Plataki; Christina Alexopoulou; Petros Ioannou; George Samonis; Antonis Valachis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-13       Impact factor: 3.267

3.  Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis.

Authors:  Márió Gajdács; Zoltán Bátori; Marianna Ábrók; Andrea Lázár; Katalin Burián
Journal:  Life (Basel)       Date:  2020-02-11

4.  Isolation, Characterization and in vitro Evaluation of Specific Bacteriophages Targeting Extensive Drug Resistance Strains of Pseudomonas aeruginosa Isolated from Septic Burn Wounds.

Authors:  Seyed Mahmoud Amin Marashi; Farhad Nikkhahi; Dariush Hamedi; Gholamhassan Shahbazi
Journal:  Infect Chemother       Date:  2022-03

Review 5.  Myths and Misconceptions around Antibiotic Resistance: Time to Get Rid of Them.

Authors:  Carlos F Amábile-Cuevas
Journal:  Infect Chemother       Date:  2022-08-05

6.  Characterization of mcr-1-Harboring Plasmids from Pan Drug-Resistant Escherichia coli Strains Isolated from Retail Raw Chicken in South Korea.

Authors:  Jinshil Kim; Bo Kyoung Hwang; HyeLim Choi; Yang Wang; Sang Ho Choi; Sangryeol Ryu; Byeonghwa Jeon
Journal:  Microorganisms       Date:  2019-09-12

7.  Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains.

Authors:  Ousmane Oumou Diallo; Sophie Alexandra Baron; Gregory Dubourg; Hervé Chaudet; Philippe Halfon; Sabine Camiade; Béatrice Comte; Stéphanie Joubert; Arnaud François; Philippe Seyral; François Parisot; Jean-Paul Casalta; Raymond Ruimy; Christophe Maruejouls; Jean-Christophe Achiardy; Sophie Burignat; Joseph Carvajal; Edouard Delaunay; Sandra Meyer; Pierre-Yves Levy; Patricia Roussellier; Patrick Brunet; Claude Bosi; Philippe Stolidi; Jean-Pierre Arzouni; Gisele Gay; Pierre Hance; Philippe Colson; Didier Raoult; Jean-Marc Rolain
Journal:  Sci Rep       Date:  2020-10-26       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.